Amdocs (DOX) Research & Development (2009 - 2026)

Amdocs (DOX) has reported Research & Development for 18 consecutive years, with $86.4 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Research & Development fell 0.56% year-over-year to $86.4 million in Q2 2026; TTM through Jun 2026 was $343.2 million, a 0.05% change from a year earlier, with the FY2025 full-year figure at $340.8 million, down 5.53% from the prior year.
• Research & Development was $86.4 million for Q2 2026 at Amdocs, down from $87.0 million in the prior quarter.
• Over five years, Research & Development peaked at $97.7 million in Q3 2023 and troughed at $81.8 million in Q1 2025.
• A 5-year average of $89.1 million and a median of $89.2 million in 2023 frame the typical range for Research & Development.
• Across the five-year window, Research & Development increased 18.31% in 2022 and slipped 10.27% in 2025, its largest moves.
• Over 5 years, Research & Development stood at $95.7 million in 2022, then slipped by 6.81% to $89.2 million in 2023, then decreased by 5.46% to $84.3 million in 2024, then declined by 2.79% to $82.0 million in 2025, then gained by 5.35% to $86.4 million in 2026.
• The last three Research & Development figures came in at $86.4 million (Q2 2026), $87.0 million (Q1 2026), and $82.0 million (Q4 2025), per Business Quant data.